Shao Lee Lin Acelyrin, Inc. (SLRN) insider trading activity

Shares Held (Direct Ownership) 1.58M

0% 3M change

2.17% 12M change

Total Value Held N/A

Shao-Lee Lin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Open market or private sale	$66,041 $6.63 p/Share	9,961 Reduced 0.63%	1,577,374 Common Stock
Feb 20 2024	SELL Open market or private sale	$119,327 $7.6 p/Share	15,701 Reduced 0.98%	1,587,335 Common Stock
Jan 02 2024	SELL Open market or private sale	$79,220 $7.41 p/Share	10,691 Reduced 0.66%	1,603,036 Common Stock
Aug 16 2023	BUY Grant, award, or other acquisition	-	842,400 Added 34.32%	1,612,434 Common Stock
May 09 2023	SELL Payment of exercise price or tax liability	$8,324,949 $24.69 p/Share	337,179 Reduced 30.45%	770,034 Common Stock
May 09 2023	SELL Other acquisition or disposition	-	1,107,213 Reduced 100.0%	0 Class A Common Stock
May 09 2023	BUY Other acquisition or disposition	-	1,107,213 Added 50.0%	1,107,213 Common Stock

HZNP

Horizon Therapeutics Public Ltd Co Healthcare

EVP, Head of R&D and CSO

SRZN

Surrozen, Inc. Healthcare

THRD

Third Harmonic Bio, Inc. Healthcare

Director

Chief Executive Officer

Dublin, L2

Receive a notification when an Institution or Guru buys or sells SLRN shares.

Notify only if

Value

Get notified when an Acelyrin, Inc. insider buys or sells SLRN shares.

Notify only if

Operation

Value

Type

Receive news related to ACELYRIN, Inc.